Figure 3 from A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors

<p>Tumor burden changes. Of the 22 patients treated, 15 (68.2%) patients were evaluable for response.</p>

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Lillian L. Siu (14851075) (author)
Další autoři:	Timothy A. Yap (15028749) (author), Sofia Genta (16724385) (author), Gregory Pennock (22547938) (author), Christine Hicking (18559919) (author), Deepthi S. Vagge (22547941) (author), Jatinder Kaur Mukker (18559913) (author), Giuseppe Locatelli (18559922) (author), Anthony W. Tolcher (18559910) (author)
Vydáno:	2025
Témata:	Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Clinical Trial Results Phase I clinical trials Drug Targets
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky